AbbVie

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AbbVie and other ETFs, options, and stocks.

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. 

CEO
Robert A. Michael
CEORobert A. Michael
Employees
50,000
Employees50,000
Headquarters
North Chicago, Illinois
HeadquartersNorth Chicago, Illinois
Founded
2011
Founded2011
Employees
50,000
Employees50,000

ABBV Key Statistics

Market cap
323.46B
Market cap323.46B
Price-Earnings ratio
63.80
Price-Earnings ratio63.80
Dividend yield
3.39%
Dividend yield3.39%
Average volume
7.76M
Average volume7.76M
High today
$183.72
High today$183.72
Low today
$182.50
Low today$182.50
Open price
$183.14
Open price$183.14
Volume
2.33M
Volume2.33M
52 Week high
$207.32
52 Week high$207.32
52 Week low
$138.01
52 Week low$138.01

ABBV News

Simply Wall St 6d
High Growth Tech Stocks To Explore In November 2024

The United States market has experienced a robust performance with a 2.2% climb over the past week and an impressive 32% increase over the last 12 months, while...

High Growth Tech Stocks To Explore In November 2024

Analyst ratings

68%

of 31 ratings
Buy
67.7%
Hold
32.3%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.